businesspress24.com - Biotech: Pressemitteilungen - Kategorie - Seite 21
 

Biotech

Category / Pharmaceuticals & Biotech / Biotech


Theratechnologies Announces Results from the Last Pivotal Phase III Trial of HIV Long Acting Biologic (LAB) Investigational Antiretroviral Ibalizumab.

MONTREAL, QUEBEC: Ibalizumab Maintains Significant Reduction of Viral Load in Patients with Multi-Drug Resistant HIV-1 Over 24 Weeks. Results from the Study Support the Regulatory Submission of the BLA to the US FDA. ...

Flamel Technologies Reports Third Quarter 2016 Results

LYON, FRANCE: Total Revenues Were $32.1 Million; 2016 Revenue Guidance Increased to $133 to $143 Million; REST-ON Phase III Trial of Micropump Sodium Oxybate Initiated ...

Neoepitope Peptides Formulated in Immunovaccine''s DepoVax(TM) Vaccine Platform Show Significant Positive Results in Preclinical Studies

HALIFAX, NOVA SCOTIA: Collaboration with UConn Health Completes First Proof-of-Concept for DPX-NEO Program Designed to Develop Patient-specific Neoepitope Immunotherapies ...

Titan Pharmaceuticals Schedules Conference Call to Review Third Quarter 2016 Financial Results

SOUTH SAN FRANCISCO, CA: Management Team to Host Conference Call Nov. 9 at 4:15 p.m. EST / 1:15 p.m. PST ...


Page 21 von 247:  « ..  20 21 22  23  24  25  26  27  28  29  .. » 247





 

Who is online

All members: 10 563
Register today: 0
Register yesterday: 0
Members online: 1
Guests online: 90


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.